BCL2 and cancer: When the body contains elevated levels of anti-apoptotic proteins such as B cell lymphoma-2 (Bcl-2) and decreased levels of pro-apoptotic proteins like Bcl2-associated X protein (BAX), cancer cells exhibit anti-apoptotic activity, and malignancy increases.